HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
IMGN holding history
ImmunoGen, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMGN overviewAll 13F holders of IMGNFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −810−100.0% | Sold out | Holders |
| Q4 2023 | 810 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 810 | $12.9K | <0.1% | −3,359−80.6% | Reduced | Holders |
| Q2 2023 | 4,169 | $78.7K | <0.1% | +3,359+414.7% | Added | Holders |
| Q1 2023 | 810 | $3.11K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 810 | $4.02K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 810 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 810 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 810 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 810 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 810 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 810 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 810 | $7.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.